{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:53:20Z","timestamp":1762955600733},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T00:00:00Z","timestamp":1476057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T00:00:00Z","timestamp":1476057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary biliary cirrhosis (PBC) is a progressive autoimmune liver disease with a long natural history. The pathogenesis of PBC is thought to be orchestrated by Th1 and\/or Th17. In this study, we investigated the role of CD4<jats:sup>+<\/jats:sup> helper T subsets and their cytokines on PBC using our previous established murine model of 2-OA-OVA immunization. We prepared adeno-associated virus (AAV)-IFN-\u03b3 and AAV-IL-4 and studied their individual influences on the natural history of autoimmune cholangitis in this model. Administration of IFN-\u03b3 significantly promotes recruitment and lymphocyte activation in the earliest phases of autoimmune cholangitis but subsequently leads to downregulation of chronic inflammation through induction of the immunosuppressive molecule IL-30. In contrast, the administration of IL-4 does not alter the initiation of autoimmune cholangitis, but does contribute to the exacerbation of chronic liver inflammation and fibrosis. Thus Th1 cells and IFN-\u03b3 are the dominant contributors in the initiation phase of this model but clearly may have different effects as the disease progress. In conclusion, better understanding of the mechanisms by which helper T cells function in the natural history of cholangitis is essential and illustrates that precision medicine may be needed for patients with PBC at various stages of their disease process.<\/jats:p>","DOI":"10.1038\/srep34884","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T11:28:46Z","timestamp":1476098926000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dual Roles of IFN-\u03b3 and IL-4 in the Natural History of Murine Autoimmune Cholangitis: IL-30 and Implications for Precision Medicine"],"prefix":"10.1038","volume":"6","author":[{"given":"Bi-Jhen","family":"Syu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-En","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hsin","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hui","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,10]]},"reference":[{"key":"BFsrep34884_CR1","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/hep.510250402","volume":"25","author":"K Harada","year":"1997","unstructured":"Harada, K. et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 25, 791\u2013796 (1997).","journal-title":"Hepatology"},{"key":"BFsrep34884_CR2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1023\/A:1020511002025","volume":"19","author":"T Nagano","year":"1999","unstructured":"Nagano, T. et al. Cytokine profile in the liver of primary biliary cirrhosis. J Clin Immunol 19, 422\u2013427 (1999).","journal-title":"J Clin Immunol"},{"key":"BFsrep34884_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jaut.2008.11.001","volume":"32","author":"RY Lan","year":"2009","unstructured":"Lan, R. Y. et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. Journal of autoimmunity 32, 43\u201351 (2009).","journal-title":"Journal of autoimmunity"},{"key":"BFsrep34884_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","volume":"156","author":"G Rong","year":"2009","unstructured":"Rong, G. et al. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol 156, 217\u2013225 (2009).","journal-title":"Clin Exp Immunol"},{"key":"BFsrep34884_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1365-2249.2009.03947.x","volume":"157","author":"K Harada","year":"2009","unstructured":"Harada, K. et al. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol 157, 261\u2013270 (2009).","journal-title":"Clin Exp Immunol"},{"key":"BFsrep34884_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1006\/clin.1996.0129","volume":"80","author":"SM Krams","year":"1996","unstructured":"Krams, S. M., Cao, S., Hayashi, M., Villanueva, J. C. & Martinez, O. M. Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol 80, 311\u2013320 (1996).","journal-title":"Clin Immunol Immunopathol"},{"key":"BFsrep34884_CR7","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","volume":"360","author":"GM Hirschfield","year":"2009","unstructured":"Hirschfield, G. M. et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 360, 2544\u20132555 (2009).","journal-title":"N Engl J Med"},{"key":"BFsrep34884_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/ng.627","volume":"42","author":"X Liu","year":"2010","unstructured":"Liu, X. et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 42, 658\u2013660 (2010).","journal-title":"Nat Genet"},{"key":"BFsrep34884_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/hep.24113","volume":"53","author":"SJ Wu","year":"2011","unstructured":"Wu, S. J. et al. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology 53, 915\u2013925 (2011).","journal-title":"Hepatology"},{"key":"BFsrep34884_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/cei.12298","volume":"177","author":"CH Chang","year":"2014","unstructured":"Chang, C. H. et al. Innate immunity drives xenobiotic-induced murine autoimmune cholangitis. Clin Exp Immunol 177, 373\u2013380 (2014).","journal-title":"Clin Exp Immunol"},{"key":"BFsrep34884_CR11","doi-asserted-by":"publisher","first-page":"e0121320","DOI":"10.1371\/journal.pone.0121320","volume":"10","author":"CH Chang","year":"2015","unstructured":"Chang, C. H. et al. Innate immunity drives the initiation of a murine model of primary biliary cirrhosis. PLoS One 10, e0121320 (2015).","journal-title":"PLoS One"},{"key":"BFsrep34884_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaut.2015.10.005","volume":"66","author":"YH Hsueh","year":"2016","unstructured":"Hsueh, Y. H., Chang, Y. N., Loh, C. E., Gershwin, M. E. & Chuang, Y. H. AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis. Journal of autoimmunity 66, 89\u201397 (2016).","journal-title":"Journal of autoimmunity"},{"key":"BFsrep34884_CR13","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/hep.24814","volume":"55","author":"D Dibra","year":"2012","unstructured":"Dibra, D. et al. Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury. Hepatology 55, 1204\u20131214 (2012).","journal-title":"Hepatology"},{"key":"BFsrep34884_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1084\/jem.20061440","volume":"204","author":"J Liu","year":"2007","unstructured":"Liu, J., Guan, X. & Ma, X. Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways. The Journal of experimental medicine 204, 141\u2013152 (2007).","journal-title":"The Journal of experimental medicine"},{"key":"BFsrep34884_CR15","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1172\/JCI4213","volume":"102","author":"S Shimoda","year":"1998","unstructured":"Shimoda, S. et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. The Journal of clinical investigation 102, 1831\u20131840 (1998).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep34884_CR16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1053\/jhep.2002.35616","volume":"36","author":"H Kita","year":"2002","unstructured":"Kita, H. et al. Analysis of TCR antagonism and molecular mimicry of an HLA-A0201-restricted CTL epitope in primary biliary cirrhosis. Hepatology 36, 918\u2013926 (2002).","journal-title":"Hepatology"},{"key":"BFsrep34884_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1053\/gast.2002.36020","volume":"123","author":"H Kita","year":"2002","unstructured":"Kita, H. et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 123, 1031\u20131043 (2002).","journal-title":"Gastroenterology"},{"key":"BFsrep34884_CR18","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.4049\/jimmunol.1001597","volume":"186","author":"GX Yang","year":"2011","unstructured":"Yang, G. X. et al. CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease. Journal of immunology 186, 1259\u20131267 (2011).","journal-title":"Journal of immunology"},{"key":"BFsrep34884_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/hep.26067","volume":"57","author":"A Dhirapong","year":"2013","unstructured":"Dhirapong, A. et al. Therapeutic effect of cytotoxic T lymphocyte antigen 4\/immunoglobulin on a murine model of primary biliary cirrhosis. Hepatology 57, 708\u2013715 (2013).","journal-title":"Hepatology"},{"key":"BFsrep34884_CR20","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/hep.28122","volume":"62","author":"S Shimoda","year":"2015","unstructured":"Shimoda, S. et al. Natural killer cells regulate T cell immune responses in primary biliary cirrhosis. Hepatology 62, 1817\u20131827 (2015).","journal-title":"Hepatology"},{"key":"BFsrep34884_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jaut.2014.01.034","volume":"50","author":"W Huang","year":"2014","unstructured":"Huang, W. et al. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells. Journal of autoimmunity 50, 123\u2013134 (2014).","journal-title":"Journal of autoimmunity"},{"key":"BFsrep34884_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"J Zhu","year":"2010","unstructured":"Zhu, J., Yamane, H. & Paul, W. E. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28, 445\u2013489 (2010).","journal-title":"Annu Rev Immunol"},{"key":"BFsrep34884_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaut.2008.04.017","volume":"31","author":"V Dardalhon","year":"2008","unstructured":"Dardalhon, V., Korn, T., Kuchroo, V. K. & Anderson, A. C. Role of Th1 and Th17 cells in organ-specific autoimmunity. Journal of autoimmunity 31, 252\u2013256 (2008).","journal-title":"Journal of autoimmunity"},{"key":"BFsrep34884_CR24","doi-asserted-by":"crossref","unstructured":"Liberal, R. et al. Cutting edge issues in autoimmune hepatitis. Journal of autoimmunity (2016).","DOI":"10.1016\/j.jaut.2016.07.005"},{"key":"BFsrep34884_CR25","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1084\/jem.180.5.1961","volume":"180","author":"MK Racke","year":"1994","unstructured":"Racke, M. K. et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. The Journal of experimental medicine 180, 1961\u20131966 (1994).","journal-title":"The Journal of experimental medicine"},{"key":"BFsrep34884_CR26","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1084\/jem.184.3.1093","volume":"184","author":"R Mueller","year":"1996","unstructured":"Mueller, R., Krahl, T. & Sarvetnick, N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. The Journal of experimental medicine 184, 1093\u20131099 (1996).","journal-title":"The Journal of experimental medicine"},{"key":"BFsrep34884_CR27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1006\/clim.2002.5299","volume":"105","author":"IH Tarner","year":"2002","unstructured":"Tarner, I. H. et al. Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4. Clin Immunol 105, 304\u2013314 (2002).","journal-title":"Clin Immunol"},{"key":"BFsrep34884_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nm804","volume":"9","author":"K Ghoreschi","year":"2003","unstructured":"Ghoreschi, K. et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 9, 40\u201346 (2003).","journal-title":"Nat Med"},{"key":"BFsrep34884_CR29","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1073\/pnas.1416922112","volume":"112","author":"E Guenova","year":"2015","unstructured":"Guenova, E. et al. IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells. Proceedings of the National Academy of Sciences of the United States of America 112, 2163\u20132168 (2015).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep34884_CR30","doi-asserted-by":"publisher","first-page":"e74225","DOI":"10.1371\/journal.pone.0074225","volume":"8","author":"K Kawata","year":"2013","unstructured":"Kawata, K. et al. Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis. PLoS One 8, e74225 (2013).","journal-title":"PLoS One"},{"key":"BFsrep34884_CR31","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/hep.23132","volume":"50","author":"K Yoshida","year":"2009","unstructured":"Yoshida, K. et al. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology 50, 1494\u20131500 (2009).","journal-title":"Hepatology"},{"key":"BFsrep34884_CR32","doi-asserted-by":"crossref","unstructured":"Bae, H. R. et al. Chronic Expression of Interferon Gamma Leads to Murine Autoimmune Cholangitis with a Female Predominance. Hepatology (2016).","DOI":"10.1002\/hep.28641"},{"key":"BFsrep34884_CR33","doi-asserted-by":"crossref","unstructured":"Vergani, D. & Mieli-Vergani, G. Mouse model of primary biliary cholangitis with a striking female predominance: A new powerful research tool. Hepatology (2016).","DOI":"10.1002\/hep.28718"},{"key":"BFsrep34884_CR34","first-page":"2434","volume":"116","author":"Z Wang","year":"2006","unstructured":"Wang, Z. et al. Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25\u2212 T cells to CD4+ Tregs. The Journal of clinical investigation 116, 2434\u20132441 (2006).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep34884_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0896-8411(91)90021-4","volume":"4","author":"M Debray-Sachs","year":"1991","unstructured":"Debray-Sachs, M. et al. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. Journal of autoimmunity 4, 237\u2013248 (1991).","journal-title":"Journal of autoimmunity"},{"key":"BFsrep34884_CR36","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.4049\/jimmunol.158.12.5997","volume":"158","author":"LS Jones","year":"1997","unstructured":"Jones, L. S. et al. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. Journal of immunology 158, 5997\u20136005 (1997).","journal-title":"Journal of immunology"},{"key":"BFsrep34884_CR37","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1189\/jlb.0806486","volume":"81","author":"H Kelchtermans","year":"2007","unstructured":"Kelchtermans, H. et al. Protective role of IFN-gamma in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 production. Journal of leukocyte biology 81, 1044\u20131053 (2007).","journal-title":"Journal of leukocyte biology"},{"key":"BFsrep34884_CR38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","volume":"31","author":"X Hu","year":"2009","unstructured":"Hu, X. & Ivashkiv, L. B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 31, 539\u2013550 (2009).","journal-title":"Immunity"},{"key":"BFsrep34884_CR39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.it.2008.07.002","volume":"29","author":"H Kelchtermans","year":"2008","unstructured":"Kelchtermans, H., Billiau, A. & Matthys, P. How interferon-gamma keeps autoimmune diseases in check. Trends in immunology 29, 479\u2013486 (2008).","journal-title":"Trends in immunology"},{"key":"BFsrep34884_CR40","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fimmu.2015.00492","volume":"6","author":"G Arellano","year":"2015","unstructured":"Arellano, G., Ottum, P. A., Reyes, L. I., Burgos, P. I. & Naves, R. Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Front Immunol 6, 492 (2015).","journal-title":"Front Immunol"},{"key":"BFsrep34884_CR41","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep.26166","volume":"57","author":"S Zhang","year":"2013","unstructured":"Zhang, S. et al. High susceptibility to liver injury in IL-27 p28 conditional knockout mice involves intrinsic interferon-gamma dysregulation of CD4+ T cells. Hepatology 57, 1620\u20131631 (2013).","journal-title":"Hepatology"},{"key":"BFsrep34884_CR42","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.4049\/jimmunol.1100883","volume":"188","author":"D Dibra","year":"2012","unstructured":"Dibra, D., Cutrera, J. J. & Li, S. Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL-30. Journal of immunology 188, 3709\u20133715 (2012).","journal-title":"Journal of immunology"},{"key":"BFsrep34884_CR43","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1002\/hep.27392","volume":"60","author":"A Mitra","year":"2014","unstructured":"Mitra, A. et al. IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice. Hepatology 60, 2027\u20132039 (2014).","journal-title":"Hepatology"},{"key":"BFsrep34884_CR44","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/ni.1957","volume":"11","author":"JS Stumhofer","year":"2010","unstructured":"Stumhofer, J. S. et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat Immunol 11, 1119\u20131126 (2010).","journal-title":"Nat Immunol"},{"key":"BFsrep34884_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaut.2013.08.003","volume":"50","author":"WP Chong","year":"2014","unstructured":"Chong, W. P. et al. IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses. Journal of autoimmunity 50, 12\u201322 (2014).","journal-title":"Journal of autoimmunity"},{"key":"BFsrep34884_CR46","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/ni1507","volume":"8","author":"HF McFarland","year":"2007","unstructured":"McFarland, H. F. & Martin, R. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8, 913\u2013919 (2007).","journal-title":"Nat Immunol"},{"key":"BFsrep34884_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair, R. P. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41, 199\u2013204 (2009).","journal-title":"Nat Genet"},{"key":"BFsrep34884_CR48","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.4049\/jimmunol.1001538","volume":"185","author":"G Tonel","year":"2010","unstructured":"Tonel, G. et al. Cutting edge: A critical functional role for IL-23 in psoriasis. Journal of immunology 185, 5688\u20135691 (2010).","journal-title":"Journal of immunology"},{"key":"BFsrep34884_CR49","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1006\/cyto.1997.0234","volume":"9","author":"A David","year":"1997","unstructured":"David, A. et al. Adenovirus-mediated gene transfer in rat liver of interleukin 4 but not interleukin 10 produces severe acute hepatitis. Cytokine 9, 818\u2013829 (1997).","journal-title":"Cytokine"},{"key":"BFsrep34884_CR50","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.4049\/jimmunol.166.8.5225","volume":"166","author":"C Guillot","year":"2001","unstructured":"Guillot, C. et al. Lethal hepatitis after gene transfer of IL-4 in the liver is independent of immune responses and dependent on apoptosis of hepatocytes: a rodent model of IL-4-induced hepatitis. Journal of immunology 166, 5225\u20135235 (2001).","journal-title":"Journal of immunology"},{"key":"BFsrep34884_CR51","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/0959-8049(93)90108-R","volume":"29A","author":"J Prendiville","year":"1993","unstructured":"Prendiville, J. et al. Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer\u2013a phase I toxicity study and pharmacokinetic analysis. Eur J Cancer 29A, 1700\u20131707 (1993).","journal-title":"Eur J Cancer"},{"key":"BFsrep34884_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1006\/clin.1997.4303","volume":"83","author":"MW Leach","year":"1997","unstructured":"Leach, M. W., Snyder, E. A., Sinha, D. P. & Rosenblum, I. Y. Safety evaluation of recombinant human interleukin-4. I. Preclinical studies. Clin Immunol Immunopathol 83, 8\u201311 (1997).","journal-title":"Clin Immunol Immunopathol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep34884.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34884","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34884.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T01:48:41Z","timestamp":1672883321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep34884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep34884"],"URL":"https:\/\/doi.org\/10.1038\/srep34884","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,10]]},"assertion":[{"value":"6 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34884"}}